Clinical Trial Update: Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB [Phase 4]

View source ↗

Summary

This Phase 4 trial assesses different administration regimens of ceftazidime-avibactam in combination with aztreonam for carbapenem-resistant Gram-negative bact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carbapenem-resistant Gram-negative Bacterial Infection

Drugs mentioned

• Avycaz (ceftazidime-avibactam)
• Azactam (aztreonam)

Snippet

Sponsor: Jing Zhou | Conditions: Ceftazidime-avibactam, Aztreonam | Phase 4 | Status: RECRUITING